A recent study of radiotherapy combined with anti-CTLA-4 antibody immunotherapy showed that the relatively large total radiation dose that can almost eradicate the primary tumor not only significantly improved the treatment outcomes of the irradiated primary tumor but also inhibited the proliferation of the unirradiated distant tumor (51). This evidence concerns the gene CTLA4 and neoplasm.